BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2011

Mar 11, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2011-03-09

Reporting Person: Davis George Eric (SVP, General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-03-09	Common Stock	M	6000	$11.74	Acquired	33901	Direct
2011-03-09	Common Stock	S	6000	$24.4944	Disposed	27901	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-03-09	Stock Option (right to buy)	$11.74	M	6000	Disposed	2016-01-05	Common Stock (6000)	Direct

Footnotes

F1: The price in Column 4 is a weighted average. The prices actually received ranged from $24.4920 to $24.511. The reporting person will provide to the issuer, any security holding of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F2: Original option grant vested 6/48ths on July 6, 2006 and 1/48th on the 6th day of every month thereafter.